| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $399K | — |
| Cost of Revenue | $127K | — |
| Gross Profit | $271K | — |
| R&D Expense | $4K | -92.2% |
| SG&A Expense | $377K | +118.0% |
| Operating Income | -$726K | -9.8% |
| Net Income | -$1.3M | +20.4% |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $202K | — |
| Current Assets | $208K | -66.8% |
| Total Assets | $4.5M | -17.1% |
| Current Liabilities | $5.5M | -1.6% |
| Total Liabilities | $5.5M | -1.6% |
| Stockholders' Equity | -$1.0M | -406.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$127K | +44.2% |
| Investing Cash Flow | -$16K | — |
| Financing Cash Flow | $149K | -34.6% |